INGALLS & SNYDER reports 6.8% of CORCEPT common stock

CORCEPT THERAPEUTICS INC: INGALLS & SNYDER, LLC amended a Schedule 13G to report beneficial ownership of 7,263,466 shares of Common Stock, representing 6.8% of the class as of 12/31/2025.

Rhea-AI Filing Summary

CORCEPT THERAPEUTICS INC: INGALLS & SNYDER, LLC amended a Schedule 13G to report beneficial ownership of 7,263,466 shares of Common Stock, representing 6.8% of the class as of 12/31/2025. The filing shows shared dispositive power over all reported shares and no sole voting or dispositive power. The amendment is signed on 04/21/2026.

Insights

Equity Ownership Analyst

13G amendment reports a sizable passive stake (6.8%) held with shared dispositive power.

INGALLS & SNYDER, LLC lists 7,263,466 shares beneficially owned as of 12/31/2025, indicating a non-control position under Schedule 13G reporting norms. The filing specifies shared dispositive authority and zero sole voting power.

Impact depends on holder intentions; subsequent filings could show shifts if trading or change-of-beneficial-ownership events occur. Timing of any trading activity is not included in this excerpt.

Key Figures

Beneficially owned shares: 7,263,466 shares Percent of class: 6.8% Filing type: Schedule 13G/A +3 more

6 metrics

Beneficially owned shares 7,263,466 shares Amount beneficially owned as reported

Percent of class 6.8% Percent of common stock owned as of 12/31/2025

Filing type Schedule 13G/A Amendment No. 17 reporting beneficial ownership

CUSIP 218352102 Identifier for CORCEPT THERAPEUTICS INC common stock

Shared dispositive power 7,263,466 shares Number of shares with shared dispositive power

Signature date 04/21/2026 Date amendment was signed

Key Terms

Schedule 13G/A, Beneficially owned, Shared dispositive power, CUSIP

4 terms

Schedule 13G/A regulatory

"Amendment No. 17 and the filing header"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned financial

"Item 4. | (a) | Amount beneficially owned: 7263466"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Shared dispositive power regulatory

"(iv) Shared power to dispose or to direct the disposition of: 7263466"

CUSIP market

"COMMON STOCK 218352102"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does INGALLS & SNYDER hold in CORT according to this filing?

The filing reports 7,263,466 shares of Common Stock, equal to 6.8% of the class as of 12/31/2025. It lists beneficial ownership and shared dispositive power over those shares.

Does INGALLS & SNYDER have voting control over CORT shares?

No. The filing states 0 shares with sole voting power and 0 with shared voting power; voting authority is not claimed in this amendment.

When was the Schedule 13G/A amendment signed for CORT?

The amendment is signed by Thomas O. Boucher, Manager on 04/21/2026, with the beneficial ownership amount reported as of 12/31/2025.

What does "shared dispositive power" mean in this filing?

Here it means INGALLS & SNYDER reports the ability to direct disposition of 7,263,466 shares jointly, rather than holding sole dispositive authority over the reported shares.

Is this a passive or active ownership filing for CORT?

This is a Schedule 13G/A filing amendment, which generally indicates a passive or qualifying investor position; the filing lists beneficial ownership without claiming sole voting control.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/21/2026 - 04:20 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 17)

CORCEPT THERAPEUTICS INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

218352102

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 218352102

1

Names of Reporting Persons

INGALLS & SNYDER LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 7,263,466.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

7,263,466.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.8 %

12

Type of Reporting Person (See Instructions)

BD, IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CORCEPT THERAPEUTICS INC
(b)	Address of issuer's principal executive offices: 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CALIFORNIA, 94065
Item 2.
(a)	Name of person filing: INGALLS & SNYDER, LLC
(b)	Address or principal business office or, if none, residence: 1 ROCKEFELLER PLAZA, NEW YORK, NY 10020
(c)	Citizenship: NEW YORK
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 218352102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 7263466
(b)	Percent of class: 6.8 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 7263466
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

INGALLS & SNYDER LLC

Signature:	THOMAS O BOUCHER JR
Name/Title:	MANGER
Date:	04/21/2026